Ibrutinib for Relapsed / Refractory Cll: An Update of the Uk and Ireland Analysis of Outcomes in 315 Patients

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley